Regulation of Dendritic Cell Migration to the Draining Lymph Node
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse DCs start to enter the regional lymph node 18 hours after inoculation in the skin, reaching a maximum within 72 hours.50,51”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“besides their critical role for priming T cells in lymph nodes (Martin-Fontecha et al., 2003)”
From Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (2018) · cites this paper as Martin-Fontecha et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336 · cited 1×
“Tissue-resident DCs and DC precursors, such as monocytes or immature DCs recruited from the blood, are stimulated by microbial products and inflammatory cytokines to undergo a coordinately regulated process of maturation and migration (1).”
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · cited 1×
“The finding that DC migration can be boosted by inflammatory stimuli through up-regulation of CCL21 on lymphatic endothelial cells was unexpected, because CCL21 has been considered the prototype of constitutive chemokines (27).”
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367 · cited 5×
“Lack of CCR7 or its ligands leads to dramatic changes in DC and lymphocyte traffic and abnormal lymph node architecture (8, 9).”
InfluentialSelf-citationAlteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690 · cited 5×
“The fact that CCR7 / DCs, which are incapable of migrating to the lymph node, do not cause lymph node congestion indicates that this phenomenon is mediated by mature DCs that have reached the lymph node through mechanisms that still need to be identified but might be related to release of chemokines or S1P.”
InfluentialDieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · cited 2×
“In plt/plt mice, which carry a spontaneous mutation that abolishes CCL19 expression and restricts CCL21 expression to the lymphatic endothelium, DCs and naive T cells fail to enter the T cell zone of secondary lymphoid organs (9, 10).”
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Cited by
Items 501–600 of 888
Exercise‐Induced Cardiac Lymphatic Remodeling Mitigates Inflammation in the Aging Heart
Roh, K., Li, H., Freeman, R. N., Zazzeron, L., Lee, A., Zhou, C., Shen, S., Xia, P., Guerra, J. R. B., Sheffield, C., et al. (2025) · Aging Cell · doi:10.1111/acel.70043 · Cited by 23
“Exercise restores fluid uptake and lymph transport in obesity-related lymphatic impairment and augments the transport of immune cells from peripheral tissues to regional lymph nodes via increased chemokine expression on lymphatic endothelial cells (LECs) (MartIn-Fontecha et al. 2003).”
Cancer vaccines: an update on recent achievements and prospects for cancer therapy
Chekaoui, A., Garofalo, M., Gad, B., Staniszewska, M., Chiaro, J., Pancer, K. W., Gryciuk, A., Cerullo, V., Salmaso, S., Caliceti, P., et al. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01541-7 · Cited by 23
Benhamron, S., Reiner, I., Zcharia, E., Atallah, M., Grau, A., Vlodavsky, I., & Mevorach, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035602 · Cited by 22
Ishii, M., Kato, C., Hakamata, A., & Kojima, N. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.011 · Cited by 22
Lymphatic Vessels in Inflammation
Vranova, M. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000250 · Cited by 25
“CCL21 expression is reportedly upregulated in vivo in the context of inflammation [61,79] and under conditions of increased lymph flow [80].”
BackgroundHarizaj, A., Clercq, O. Q. D., Descamps, B., Vanhove, C., Smedt, S. C. D., Poelman, D., Lentacker, I., & Braeckmans, K. (2019) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201900371 · Cited by 23
Pegu, A., Flynn, J. L., & Reinhart, T. A. (2007) · Lymphatic Research and Biology · doi:10.1089/lrb.2007.1006 · Cited by 24
“Cells expressing CCL20 mRNA were localized almost exclusively to subcapsular regions of HLNs and MLNs, and all of these cells were podoplanin (cid”
InfluentialChen, Y., Hwang, S., Chan, V. S. F., Chung, N. P. Y., Wang, S., Li, Z., Ma, J., Lin, C.-W., Hsieh, Y., Chang, K., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003100 · Cited by 24
“For example, the magnitude and quality of the CD4 T cell response is proportional to the number of antigen-bearing DC that reach the lymph nodes [17].”
BackgroundPGI2 signaling inhibits antigen uptake and increases migration of immature dendritic cells
Toki, S., Goleniewska, K., Huckabee, M. M., Zhou, W., Newcomb, D. C., FitzGerald, G. A., Lawson, W. E., & Peebles, R. S. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112559 · Cited by 22
“In comparison with our migration studies using immature BMDCs, other groups found that LPS-treated mature DCs migrated to the popliteal LNs 24–48 h after injection [40, 41].”
ResultUnravelling the mechanisms of help for CD8+ T cell responses
Livingstone, A. M., Wilson, E. B., Ontiveros, F., & Wang, J.-C. E. (2009) · Immunologic Research · doi:10.1007/s12026-009-8102-0 · Cited by 22
“In contrast, TNFa had no effect on the CD8? T cell response, even though it stimulated DC maturation in vitro, and caused substantial lymphocyte accumulation in the draining lymph node when injected a few hours before immunization [44].”
BackgroundTawab, A., Fan, Y., Read, E. J., & Kurlander, R. J. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.02020.x · Cited by 24
Tesar, B. M., Chalasani, G., Diggs, L., Baddoura, F. K., Lakkis, F. G., & Goldstein, D. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4377 · Cited by 22
“Furthermore, impairing DC migration by inhibiting the CCR7-CCL21 pathway impedes T and B cell priming (9, 10).”
BackgroundMullins, D. W., & Engelhard, V. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4535 · Cited by 24
“injection, maximal numbers of DC in popliteal LN are not achieved until 2–4 days (19, 26).”
BackgroundResultInfluentialThe importance of type I interferon in orchestrating the cytotoxic T-cell response to cancer
Busselaar, J., Sijbranda, M., & Borst, J. G. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106938 · Cited by 22
Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
Batich, K. A., Swartz, A. M., & Sampson, J. H. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.972361 · Cited by 21
“Preclinical investigations have revealed that pre-conditioning the vaccine site with inflammatory cytokines or mature DCs significantly increases the migration of a subsequent DC vaccine to draining lymph nodes, which then proportionally increased the magnitude of the CD4 T-cell response [51].”
BackgroundEfficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route
Edele, F., Dudda, J. C., Bachtanian, E., Jakob, T., Pircher, H., & Martin, S. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105266 · Cited by 24
“It has to be considered that only CCR7 mature antigen-pulsed DC efficiently migrate to the draining LN and induce T cell proliferation [34] and that the route of DC injection determines the distribution of effector and memory T cells [15,35–37].”
BackgroundAarntzen, E. H. J. G., Srinivas, M., Schreibelt, G., Heerschap, A., Punt, C. J. A., Figdor, C. G., Oyen, W. J. G., & de Vries, I. J. M. (2013) · OncoImmunology · doi:10.4161/onci.24661 · Cited by 21
Membrane water permeability related to antigen-presenting function of dendritic cells
Wang, G. F., Dong, C., Tang, G., Shen, Q., & Bai, C. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03702.x · Cited by 21
Mou, Y., Su, H., An, Y., Han, W., Huang, X., Xia, G., Ni, Y., Zhang, Y. X., Ma, J., & Hu, Q. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s52135 · Cited by 21
Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis
Bardina, S. V., Brown, J. A., Michlmayr, D., Hoffman, K. W., Sum, J., Pletnev, A. G., Lira, S. A., & Lim, J. K. (2017) · Journal of Virology · doi:10.1128/jvi.02409-16 · Cited by 22
Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine
Xu, H., & Cao, X. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0172-4 · Cited by 21
Keon, S. M., Gazzaniga, S., Mallerman, J., Bravo, A., Mordoh, J., & Wainstok, R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.095 · Cited by 20
A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen
Rush, C. M., Mitchell, T. J., & Garside, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.014 · Cited by 20
Site-Specific DC Surface Signatures Influence CD4+ T Cell Co-stimulation and Lung-Homing
Pejoski, D., Ballester, M. C., Auderset, F., Vono, M., Christensen, D., Andersen, P. L., Lambert, P., & Siegrist, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01650 · Cited by 20
Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers
King, R., Hayes, C., Donohoe, C. L., Dunne, M. R., Davern, M., & Donlon, N. E. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i5.312 · Cited by 25
TNF controls the infiltration of dendritic cells into the site of Leishmania major infection
Ritter, U., Lechner, A., Scharl, K., Kiafard, Z., Zwirner, J., & Körner, H. (2007) · Medical Microbiology and Immunology · doi:10.1007/s00430-007-0056-z · Cited by 24
“The presence of the proinXammatory cytokine tumor necrosis factor (TNF) at the site of challenge is essential to achieve an eVective migration of a suYcient number of antigen-presenting DC [ 4 ].”
BackgroundResultInfluentialDendritic cells: therapy and imaging
Pham, W. N., Kobukai, S., Hotta, C., & Gore, J. C. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902867739 · Cited by 22
Sharma, R., Chheda, Z. S., Jala, V. R., & Haribabu, B. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.982101 · Cited by 20
“was shown that CCR7-deficient DCs are defective in migrating to dLNs after sampling antigens [41,42].”
BackgroundInfluentialGeography and plumbing control the T cell response to infection
Khanna, K. M., & Lefrançois, L. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.22 · Cited by 23
Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist
Ryu, K. A., McGonnigal, B., Moore, T., Kargupta, T., Mancini, R. J., & Esser-Kahn, A. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08520-x · Cited by 20
Arjmandi, A., Liu, K., & Dorovini‐Zis, K. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31819a8dd1 · Cited by 22
Frontline: Peripheral priming of alloreactive T cells by the direct pathway of allorecognition
Baratin, M., Bonin, K., & Daniel, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200425309 · Cited by 21
Mendelson, M., Hanekom, W. A., Ntutela, S., Vogt, M., Steyn, L. M., Maartens, G., & Kaplan, G. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00132-06 · Cited by 20
“We hypothesize that the maturation of mDCs in blood either in direct response to bacteria during bacteremia or in response to a proinflammatory milieu will direct maturing mDCs to lymph nodes, thereby positively affecting the immune response (13).”
BackgroundTripp, C. H., Haid, B., Flacher, V., Sixt, M., Peter, H., Farkas, J., Gschwentner, R., Sorokin, L. M., Romani, N., & Stoitzner, P. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.025 · Cited by 22
“The main DC population are Langerin-negative dermal dendritic cells ( Lenz et al., 1993 ).”
BackgroundModulation of antitumor responses by dendritic cells
Vieweg, J., & Jackson, A. M. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0175-1 · Cited by 21
“Murine studies have shown that pre-injection of the proinflammatory cytokines TNF-a and IL-1-a into cutaneous tissues enhanced migration of antigen-bearing DC to the regional lymph nodes [30].”
BackgroundSlatter, T. L., Wilson, M., Tang, C., Campbell, H. G., Ward, V. K., Young, V. L., Ly, D. V., Fleming, N. I., Braithwaite, A. W., & Baird, M. A. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1112941 · Cited by 19
“Although relatively large numbers of DC are used in immunotherapeutic strategies, it has been known for some time that only a low percentage of those administered in vivo actually arrive at the draining lymph nodes.(23) Our evidence now suggests an explanation: the high degree of cell death is brought Figure 4.”
BackgroundHost transcriptome response to Borrelia burgdorferi sensu lato
Thompson, D., Watt, J. A., & Brissette, C. A. (2020) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2020.101638 · Cited by 22
Tripp, C. H., Ebner, S., Ratzinger, G., Romani, N., & Stoitzner, P. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181b8ef5f · Cited by 19
“Furthermore, in our experiments we confirmed and extended recent findings that DC migration is dependent on the number of injected cells.(13,44) We detected higher numbers of immigrated DCs after injecting increased doses of DCs, whereas the migration rate decreased, an effect similarly described by Mullins and Engelh…”
BackgroundResultInfluentialDendritic cell vaccines in acute leukaemia
Duncan, C., & Roddie, H. (2008) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.07.010 · Cited by 23
In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells
Crisci, E., Fraile, L. J., Novellas, R., Espada, Y., Cabezón, R., Martínez, J., Córdoba, L., Bárcena, J., Benítez‐Ribas, D., & Montoya, M. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.08.006 · Cited by 20
Hu, L., Bray, M. D., Geng, Y., & Kopecko, D. J. (2012) · Infection and Immunity · doi:10.1128/iai.00129-12 · Cited by 19
“The migratory capacity is controlled by the expression of chemokine receptors, especially CCR7 on the surfaces of DCs (11, 21).”
BackgroundMacropinocytosis: Molecular mechanisms and regulation
Tu, H., Wang, H., & Cai, H. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102563 · Cited by 20
A Mathematical Modelling of Initiation of Dendritic Cells-Induced T Cell Immune Response
Huang, W., Hu, W., Yun, W., Chen, J., Hu, Z., Zhou, J., Liu, L., Qiu, W., Tang, F., Zhang, S., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33412 · Cited by 18
“If t>tthresh, the migration rate can enhance about three times, when the DCs in PT increase approximately two times [4, 21, 22], so we set”
BackgroundUnraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing
Song, L., Gong, Y., Wang, E., Huang, J., & Li, Y. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231210274 · Cited by 21
Targeting SIRP‐α protects from type 2‐driven allergic airway inflammation
Raymond, M., Van, V. Q., Rubio, M., Welzenbach, K., & Sarfati, M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040797 · Cited by 18
Exogenous dendritic cell homing to draining lymph nodes can be boosted by mast cell degranulation
Ren, S., Xu, L., Wu, Z., Du, J., Gao, M., & Qu, C. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.03.017 · Cited by 18
Myster, F., Palmeira, L., Sorel, O., Bouillenne, F., Pauw, E. D., Schwartz-Cornil, I., Vanderplasschen, A. F. C., & Dewals, B. G. (2015) · Journal of Virology · doi:10.1128/jvi.03634-14 · Cited by 18
“BMDCs were then labeled with CFSE before injected subcutaneously into the footpad of syngeneic IIIEP/J rabbits according to a published protocol (45).”
MethodRossowska, J., Pajtasz‐Piasecka, E., Szyda, A., Ziętara, N., & Duś, D. (2007) · PubMed · doi:10.5603/4507 · Cited by 18
T cell priming by tissue-derived dendritic cells: New insights from recent murine studies
Sillé, F. C. M., Visser, A., & Boes, M. L. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.10.004 · Cited by 18
Begum, M. D., Umemura, M., Kon, S., Yahagi, A., Hamada, S., Oshiro, K., Gotoh, K., Nishizono, A., Uede, T., & Matsuzaki, G. (2007) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2007.tb03884.x · Cited by 19
Interactions of Immune Cells and Lymphatic Vessels
Kataru, R. P., Lee, Y. G., & Koh, G. Y. (2013) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-7091-1646-3_9 · Cited by 18
Wirsdörfer, F., Bangen, J., Pastille, E., Schmitz, D., Flohé, S., Schumak, B., & Flohé, S. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155870 · Cited by 18
“The number of DCs, their state of maturation, and the microenvironment during antigen uptake are decisive for the degree of subsequent T helper (Th) cell priming in the lymphoid organ [6].”
BackgroundArina, A., Murillo, O., Hervás‐Stubbs, S., Azpilikueta, A., Dubrot, J., Tirapu, I., Huarte, E., Alfaro, C., Perez‐Gracia, J. L., González‐Aseguinolaza, G., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22795 · Cited by 19
“as in the dramatic increase in the number of lymphocytes inside the responding lymphoid tissue.(66) IFNg secreted by NK cells is at least one of the factors involved in those effects.”
BackgroundGliadin fragments promote migration of dendritic cells
Chladkova, B., Kamanová, J., Palová-Jelínková, L., Cinová, J., Šebo, P., & Tučková, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01066.x · Cited by 18
“DC migration to LNs is directed by the chemokine receptor CCR7 [31], expression of which is up-regulated during DC maturation.”
BackgroundSeth, A., Heo, M. B., Sung, M., & Lim, Y. T. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.02.013 · Cited by 17
Interplay between Inflammatory Responses and Lymphatic Vessels
Shin, K., & Lee, S. (2014) · Immune Network · doi:10.4110/in.2014.14.4.182 · Cited by 19
Li, C.-H., Zhang, J., Baylink, D. J., Wang, X., Goparaju, N., Xu, Y., Wasnik, S., Cheng, Y., Berumen, E. C., Qin, X., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601243r · Cited by 20
“Antibodies used in this study included: APC-CD3 (clone 17A2), PerCP-CD4 (clone RM4-5), FITC-IL-4 (clone BVD6-2442), FITC-IL-5 (clone TRFK5), FITC-IL-13 (clone Ebio13A), FITC-IL-10 (clone JESS-16E3), PE-foxp3 (clone FJK-16S), all from Thermo Fisher Scientific (Waltham, MA, USA), and PE-CCR7 (clone 4B12; BioLegend, San…”
BackgroundAntisense therapy for restenosis following percutaneous coronary intervention
Kipshidze, N. N., Tsapenko, M. V., Iversen, P. L., & Burger, D. R. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.79 · Cited by 17
IL-12-Impaired and IL-12-Secreting Dendritic Cells Produce IL-23 upon CD154 Restimulation
Jasny, E., Eisenblätter, M., Mätz‐Rensing, K., Tenner‐Racz, K., Tenbusch, M., Schrod, A., Stahl‐Hennig, C., Moos, V., Schneider, T., Rácz, P., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6629 · Cited by 16
“GA/d-cAMP and cytokine-activated DCs displayed an identical phenotype regarding expression of surface molecules, including high expression of the homing receptor to secondary lymphoid tissues, CCR7 (51) (Fig.”
BackgroundMultimodality Imaging of Bone Marrow–Derived Dendritic Cell Migration and Antitumor Immunity
Ahn, S.-B., Lee, S. B., Singh, T. D., Cho, S. J., Kim, S. K., Lee, I., Jeong, S. Y., Ahn, B., Lee, J., Lee, S., et al. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.003 · Cited by 16
“It has been demonstrated that preexposure of the injection site to proinflammatory cytokines such as TNF-α results in enhanced DC migration to draining lymph nodes [27].”
Backgroundda Silva, L. B. R., Taira, C. L., Dias, L. D. S., Souza, A. C. O., Nosanchuk, J. D., Travassos, L. R., & Taborda, C. P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01727 · Cited by 16
Chapter 2 New Insights into the Roles of Dendritic Cells in Intestinal Immunity and Tolerance
Cerovic, V., McDonald, V., Nassar, M. A., Paulin, S. M., MacPherson, G. G., & Milling, S. W. F. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01602-x · Cited by 17
Adrenergic Modulation of Dendritic Cell Cancer Vaccine in a Mouse Model
Botta, F., & Maestroni, G. J. M. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318160995e · Cited by 16
“An increased inflammatory response should boost the migration of mDCs but not that of iDCs.(7) In our case, the migration of mDCs-OVA was indeed higher than that of iDCs-OVA upon PGN preconditioning.”
BackgroundSimões, R. D., Howard, K. E., & Dean, G. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037606 · Cited by 16
Anis, M. M., Fulton, S. A., Reba, S. M., Harding, C. V., & Boom, W. H. (2007) · Infection and Immunity · doi:10.1128/iai.01709-06 · Cited by 16
“Greater numbers of Fluos-OVA-containing DCs in infected mice could result in activation of more OVA-specific naive T cells (26).”
BackgroundFLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines
Kreiter, S., Diken, M., Selmi, A., Petschenka, J., Türeci, Ö., & Şahin, U. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3625-0_11 · Cited by 16
Goudin, N., Chappert, P., Megret, J., Gross, D., Rocha, B., & Azogui, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157822 · Cited by 18
“This observation is in agreement with previous reports, which show that mature DCs control lymphocyte entry to LN through HEVs, modifying the lymphocyte traffic and the magnitude of the effector response [31, 32].”
ResultTsc1 expression by dendritic cells is required to preserve T-cell homeostasis and response
Luo, Y., Li, W., Yu, G., Yu, J., Han, L., Xue, T., Sun, Z., Chen, S., Fang, C., Zhao, C., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.487 · Cited by 17
“The magnitude and quality of T-cell response is directly proportional to the number of antigen-pulsed DCs that arrived at the draining lymph nodes (LNs).(25) The defective induction of antigen-specific T-cell responses by Tsc1-deficient DCs may be due to the decreased number of antigen-carrying DCs from the site of th…”
BackgroundImaging leukocyte migration through afferent lymphatics*
Collado‐Díaz, V., Medina-Sanchez, J. D., Gkountidi, A., & Halin, C. (2021) · Immunological Reviews · doi:10.1111/imr.13030 · Cited by 17
Modulation of Pulmonary Dendritic Cell Function during Mycobacterial Infection
Anis, M. M., Fulton, S. A., Reba, S. M., Liu, Y., Harding, C. V., & Boom, W. H. (2007) · Infection and Immunity · doi:10.1128/iai.01079-07 · Cited by 16
“Chemokine receptor CCR7 expression is essential for the migration of DCs to the lymph nodes, where they coordinate adaptive immune responses following TLR stimulation (9, 17, 23, 33, 34).”
BackgroundMatthews, K. E., Qin, J., Yang, J., Hermans, I. F., Palmowski, M. J., Cerundolo, V., & Ronchese, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5738 · Cited by 18
“Experimental evidence indicates that the number of Ag-loaded DC in the lymph node correlates with the level of proliferation and cytokine secretion by T cells, and the generation of delayed-type hypersensitivity responses (7).”
BackgroundGarside, P., & Brewer, J. M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00587.x · Cited by 18
“CCL21/CCR7 (23, 122)] close to HEVs, where they are ideally positioned to meet T cells migrating and localizing under the influence of the same chemokines (123).”
BackgroundCurrent State and Perspectives of Dendritic Cell Vaccination in Cancer Immunotherapy
Farkas, Á., Conrad, C., Tonel, G., Borbényi, Z., Kemény, L. V., DOBOZY, A., & Nestle, F. O. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000092592 · Cited by 21
Do ApoptoticPlasmodium‐Infected Hepatocytes Initiate Protective Immune Responses?
Rénia, L., Marañón, C., Hosmalin, A., Grüner, A. C., Silvie, O., & Snounou, G. (2005) · The Journal of Infectious Diseases · doi:10.1086/498536 · Cited by 16
“after they take up parasite antigens directly from viable infected hepatocytes in a process similar to that recently described for HIV-infected cells [7] and for tumor cells [8].”
BackgroundGeneration of antitumor response by IL-2-transduced JAWS II dendritic cells
Rossowska, J., Pajtasz‐Piasecka, E., Ryśnik, O., Wojas-Turek, J., Krawczenko, A., Szyda, A., & Duś, D. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.05.006 · Cited by 15
Slight-Webb, S. R., Lin, Y., Messmer, M. N., & Khader, S. A. (2011) · Cytokine · doi:10.1016/j.cyto.2011.05.017 · Cited by 15
“Activated DCs upregulate chemokine receptors, specifically Chemokine-C-Receptor 7 (CCR7) and migrate to secondary lymphoid organs in response to the homeostatic chemokine such as chemokine (C–C motif) ligand 19 (CCL19) [4,5].”
BackgroundDistinct features of dendritic cell-based immunotherapy as cancer vaccines
Lee, C., Lee, M., & Rhee, I. (2018) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2018.7.1.16 · Cited by 15
“Circulating DCs and their precursors exit the blood via tissuespecific recruitment signals such as chemokines that derive from sites of inflammation [17].”
BackgroundFeng, X., Classon, C., Terán, G., Yang, Y., Li, L., Chan, S. C.-L., Ribacke, U., Rothfuchs, A. G., Coquet, J. M., & Nylén, S. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007008 · Cited by 15
Johnson, S. C., Frattolin, J., Edgar, L. T., Jafarnejad, M., & Moore, J. E. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0464 · Cited by 17
Busch, R., Siah, I. M., Gee, T. A., & Hellerstein, M. K. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.05.014 · Cited by 16
Savinov, A. Y., & Burn, P. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.013 · Cited by 15
Role of dendritic cells in the regulation of antitumor immunity
Wathelet, N., & Moser, M. (2013) · OncoImmunology · doi:10.4161/onci.23973 · Cited by 15
Murine gammaherpesvirus-68 productively infects immature dendritic cells and blocks maturation
Hochreiter, R., Ptaschinski, C., Kunkel, S. L., & Rochford, R. A. (2007) · Journal of General Virology · doi:10.1099/vir.0.82931-0 · Cited by 16
“In particular, CCR7, which responds to the chemokines CCL19 and CCL21, is important for directing DCs to the lymphoid organs (Martin-Fontecha et al., 2003; Sallusto et al., 1998).”
BackgroundAdaptive Immune Response in JAM-C-Deficient Mice: Normal Initiation but Reduced IgG Memory
Zimmerli, C., Lee, B. P.-L., Palmer, G., Gabay, C., Adams, R. H., Aurrand‐Lions, M., & Imhof, B. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803892 · Cited by 16
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Kaufman, H. L., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8 · Cited by 18
Moser, M. (2004) · Nature Immunology · doi:10.1038/ni0604-559 · Cited by 15
Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury
Lv, D., Jiang, H., Yang, X., Li, Y., Niu, W., & Zhang, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1294807 · Cited by 16
Kim, S., Pham, T.-N. N., Hoang, T. M. N., Kang, H., Jin, C.-J., Nam, J., Chung, S.-Y., Choi, S.-J.-N., Yang, D., Kim, Y., et al. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0721-y · Cited by 14
“However, animal models indicate that a higher immunization frequency and higher DC doses generally promote induction of immunity [9, 17].”
Li, X., Wu, Y., Wang, S., Liu, J., Zhang, T., Wei, Y., Zhu, L., Bai, W., Ye, T., & Wang, S. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109119 · Cited by 14
Wu, W., Ho, L., Chen, P.-C., Tsai, Y.-T., Hsu, S.-T., Chang, D., & Lai, J. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9578-7 · Cited by 14
“Meanwhile, DENV-induced expression of CCR7, a receptor essential for DCs migration to the T cell area of draining lymph nodes [48, 49], on moDCs was also inhibited by leflunomide.”
BackgroundGaffal, E., Schweichel, D., Tormo, D., Steitz, J., Lenz, J., Basner‐Tschakarjan, E., Limmer, A., & Tüting, T. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.07.002 · Cited by 14
Qin, W., Wang, L., Zhai, R., Ma, Q., Liu, J., Bao, C., Sun, D., Zhang, H., Sun, C., Feng, X., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.12.004 · Cited by 14
Qu, P., Ji, R., Shimoda, H., Miura, M., & Kato, S. (2004) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.20071 · Cited by 14
Eppert, B. L., Motz, G. T., Wortham, B. W., Flury, J. L., & Borchers, M. T. (2010) · Infection and Immunity · doi:10.1128/iai.00962-09 · Cited by 15
“CCR7 expression is regulated in response to immune stimulation, and increased receptor expression is known to modulate cellular activation (26, 29).”
BackgroundRecent advances in tumour antigen‐specific therapy: In vivo veritas
Mahnke, Y. D., Speiser, D. E., Luescher, I. F., Cerottini, J., & Romero, P. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20572 · Cited by 15
Buffa, D. J., O’Neil, T. R., Vine, E. E., Sarkawt, L., van Dijk, F. A. W., Dong, O. A., Nasr, N., Cunningham, A. L., Bertram, K. M., & Harman, A. N. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013490 · Cited by 14
“Secondly, molecules associated with chemotaxis and lymphatic drainage are increased, particularly CCR7, which mediates migration to T cell-rich lymph nodes along CCL19 and CCL21 chemotactic gradients [35,125–127].”
Transcriptional IL-15-directed in vivo DC targeting DNA vaccine
Tian, S., Liu, Z., Carey, C. D., Noh, H. S., Falo, L. D., & You, Z. (2009) · Gene Therapy · doi:10.1038/gt.2009.110 · Cited by 13
Dendritic Cells Modified by Vitamin D: Future Immunotherapy for Autoimmune Diseases
Pedersen, A. W., Claësson, M. H., & Zocca, M.-B. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-386960-9.00003-4 · Cited by 17
Laere, M. D., Derdelinckx, J., Hassi, M., Kerosalo, M., Oravamäki, H., den Bergh, J. V., Berneman, Z. N., & Cools, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01964 · Cited by 13
Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma
Ren, S., Wang, Q., Zhang, Y., Song, Y., Dong, X., Zhang, W., Qin, X., Liu, M., & Yu, T. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.026 · Cited by 14
Metadata
- Authors
- Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
- Affiliations
- 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
- Institute for Research in Biomedicine (CH)
- 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
- Max Delbrück Center (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 615-621
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194169
- OpenAlex
- W2149057253
- Cited by
- 878
- References
- 29
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Science Foundation
- Institute for Research in Biomedicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
- Helmut Horten Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
- MeSH terms
- Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.